Conjugate Group provides flexible drug development services to help de-risk the drug development process.

Conjugate Group

Alter provides a personalized fitness system that utilizes DNA and biometric data to create individualized fitness plans and monitor health metrics.

Alter

Conjugate Group | 1,976 followers on LinkedIn. Flexible Drug Development | The Conjugate Group provides flexible drug development services and resources. The scope of our services ranges from strategic consulting and functional staff augmentation to comprehensive, deliverable-based solutions starting from IND Enabling through Commercial launch.

Our people are industry veterans with numerous accolades and accomplished careers in their respective areas of expertise.

Building innovative and creative solutions to bridge the gap between resources, timelines and budget, for drug development and device companies and…

Patrick Gill

Project Manager | Lab Operations Manager | Cross Functional Collaboration | Risk | Budget Management | Biopharma | Diagnostics

Gina Brower, PMP®

Representing the best clinical development professionals in the biotech and pharmaceutical industries

Jesse Nandhavan

Drug Development Strategy and Execution

Sean Malkus

One of our fantastic clinical science consultants, Marjorie Zettler, PhD, MPH , penned an article outlining updated FDA guidance for dose optimization in drug development. It highlights how companies incorporating this kind of study design can provide a real benefit to their patient populations, particularly in the Oncology sector where tolerability and risk are massive drivers. Very much worth a read, and if your company is doing this, it would be great to hear about how it has shaped approval, uptake, and outcomes! https://lnkd.in/eDj2fc5N

Thank you to our troops, our veterans, and our heroes! We hope everyone is enjoying this Memorial Day, but especially those who have served this great country.

Rare diseases have been a cornerstone of our work since our inception. Working as a partner to the biotech community, many of our clients are promoting cutting edge and novel therapies for these conditions, which without the efforts of insightful investors, gifted scientists, and indefatigable clinical researchers would not be possible. Today, on Rare Disease Day, we stand together to raise awareness and advocate for those affected by these conditions. At Conjugate Group, we're not just observers; we're actively engaged in the fight, and we're dedicated to contributing to clinical progress and aiding discovery efforts to find cures. Supporting Rare Disease Research: From trial design, to approval pathways, to study management, we facilitate connections between passionate experts and organizations driving breakthroughs in rare disease research. we're here to support recruitment needs on the frontline against rare diseases. Join Us: This Rare Disease Day, let's drive change together. Whether you're a rare disease expert in a function we represent, or a company seeking top-tier talent, let's connect. Together, we can overcome rare diseases and pave the way for a healthier future #MedicalRareDiseaseDay #RareDiseaseAwareness #ConjugateGroup #DrugDevelopment #ClinicalProgress #LifeSciences #JoinTheFight

🚀 Exciting News! 🚀 We are thrilled to share that Conjugate Group, a leader in Flexible Drug Development™ services, has expanded its offerings to include Executive Search. This strategic move reinforces our commitment to client success in the Biopharmaceutical industry. With a strong track record in Consulting and Contract Services, we're now uniquely positioned to provide tailored Executive Search solutions. Our Group will help organizations secure top-tier executive talent, empowering them to build visionary leadership teams in the dynamic landscape of drug development. Strong leadership is pivotal to success, and our Executive Search services aim to facilitate just that. Read the full press release here: https://lnkd.in/e2f-s7hZ #ConjugateGroup #ExecutiveSearch #Biopharmaceutical #DrugDevelopment #LeadershipSolutions #InnovationInHealthcare

Metric
Company Name	Conjugate Group	Alter
Symbol
MSH ID	COM:CONJUGATEGROUP	COM:ALTERME
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Consumer Services
Industry	Pharmaceuticals	Health & Fitness
Country	US	US
Stage
Employee Count
Website	conjugategroup.com	alterme.com
LinkedIn	conjugategroup	altermedotcom
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	49
Web Traffic Growth	0.06
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CONJ

COM:CONJUGATEGROUP

Conjugate Group

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue